Baxter International | BAX - Bruttoergebnis Vom Umsatz

Aktienkurs
17.09
Täglich Wechseln
-0.53 -3.01%
Monatlich
-19.92%
Jährlich
-49.87%
Q1 Prognose
16.87




Bruttoergebnis Vom Umsatz Veränderung Datum
Abbott USD 6.54B 625M 2025-12
AngioDynamics USD 44.78M 2.93M 2025-09
Artivion USD 73.14M 1.25M 2025-12
AtriCure USD 105.34M 4M 2025-12
Avanos Medical USD 86M 0 2025-12
Baxter International USD 577M 373M 2025-12
Becton, Dickinson and Co. USD 2.41B 1.72B 2025-12
Boston Scientific USD 3.68B 136M 2025-12
Cooper Companies USD 695.2M 44.4M 2025-12
Dexcom USD 792.7M 61.3M 2025-12
Edwards Lifesciences USD 1.23B 18.7M 2025-12
Fresenius EUR 1.51B 214M 2025-12
Globus Medical USD 535.95M 49.28M 2025-12
Halozyme Therapeutics USD 281.77M 2.41M 2025-09
ICU Medical USD 202.98M 2.1M 2025-12
Inogen USD 41.34M 1.39M 2024-09
Insulet USD 568.6M 58.5M 2025-12
Integra LifeSciences USD 217.1M 10.11M 2025-12
Intuitive Surgical USD 1.9B 241.9M 2025-12
J&J USD 16.6B 118M 2025-12
Laboratory Of America USD 993.2M 31.9M 2025-12
Masimo USD 247.3M 16.7M 2025-12
Medtronic USD 5.41B 27M 2025-12
Merit Medical Systems USD 195.35M 8.94M 2025-12
Quest Diagnostics USD 873M 37M 2025-12
Smith & Nephew USD 2.09B 117M 2025-12
Stryker USD 4.49B 633M 2025-12
Tandem Diabetes Care USD 167.46M 33.17M 2025-12
Teleflex USD 307.45M 144.2M 2025-12
Terumo JPY 153.19B 6.2B 2025-12
Zimmer Biomet Holdings USD 1.27B 8.1M 2025-12